Harrow Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on January 12, 2023, covering events occurring on January 11, 2023. The filing details the completion of a debt financing transaction involving the issuance of senior notes.
Key Financial Metrics
- Debt Issuance: The Company issued an additional $5,250,000 aggregate principal amount of 11.875% Senior Notes due 2027.
- Total Offering Size: Combined with the initial $35,000,000 issuance on December 20, 2022, the total aggregate principal amount of Notes issued is $40,250,000.
- Interest Rate: 11.875% per annum.
- Maturity Date: 2027.
- Use of Proceeds: Net proceeds are expected to fund a portion of the purchase price for a previously announced acquisition.
- Revenue and Profit: The filing text does not provide a clear value for revenue, profit, cash flow, or margins as this is a transaction-specific report.
Material Changes
The primary material change is the full exercise of the underwriters' option to purchase additional notes. This increased the total debt obligation under this specific indenture by $5,250,000 compared to the initial closing in December 2022. The newly issued notes carry identical terms to the initial tranche.
Outlook, Risks, and Management Commentary
Management indicated that the proceeds from the total $40,250,000 offering will be utilized to support a strategic acquisition. The notes are governed by an indenture with U.S. Bank Trust Company, National Association. No specific risks or contingencies beyond standard debt obligations were detailed in this specific excerpt.
Investor Verification Checklist
- Verify the specific terms of the "previously announced acquisition" to understand the strategic rationale for the debt issuance.
- Review the December 20, 2022 Form 8-K for the full text of the Indenture and covenants associated with the 11.875% Senior Notes.
- Confirm the exact net proceeds received after deducting underwriting discounts and expenses.
- Assess the impact of the 11.875% interest rate on the company's future interest expense and liquidity position.